Openning ceremony, May 25

BIG HALL

Opening Ceremony

16.30 – 16.35 Opening speech – Alexander Rumyantsev (Russia)

16.35 – 16.40 Russian Government representative speech (Russia)

16.40 – 16.45 Welcoming from the Russian Ministry of Health – Veronika Skvortsova (Russia)

16.45 – 16.50 Salutation from WHO – Oleg Chestnov (Switzerland)

16.50 – 16.55 SIOP Board welcoming speech – Paul Rogers (Canada)

16.55 – 17.00 SIOP Asia President Salutation – Chi-Kong Li (Hong Kong S.A.R.)

17.00 – 17.05 UICC Welcome speech – Tezer Kutluk (Turkey)

17.05 – 17.10 CCI Welcoming speech – Carmen Auste (Philippines)

17.10 – 17.20 Survivors (Families: Kabanovi, Mayorovi, Levitskie)

17.20 – 17.30 A special song presentation from CCI – child4child

17.30 – 18.00 Salutations

Congress halls

Main halls:

BIG HALL – 1.200 places

RED/BLUE HALL – 200 places

BIEGE/GREEN HALL – 100 places

Special halls:

• Lounge
• Meeting room
• Speakers ready room
• Interview zone

Thursday, May 26

BIG HALL

8.00 – 9.45 Plenary session: Acute lymphoblastic leukaemia

Chairs: Paul S. Gaynon (USA), Guenter Henze (Germany)

8.00 – 8.15 Acute lymphoblastic leukemia treatment strategies – the Asian experience – Chi-Kong Li (Hong-Kong S.A.R.)

8.15 – 8.30 Acute lymphoblastic leukemia treatment: past, present, future – Guenter Henze (Germany)

8.30 – 8.45 Acute lymphoblastic leukemia treatment in Russia: the unique experience – Alexander Karachunsky (Russia)

8.45 – 9.00 Evolution of Acute lymphoblastic leukemia treatment in United States – Paul S. Gaynon (USA)

9.00 – 9.15 Acute lymphoblastic leukemia at Adolescents and Young Adults – Paul Rogers (Canada)

9.15 – 9.45 Discussion

-------------

BIG HALL

10.00 – 11.30 Parallel session: Acute lymphoblastic leukaemia

Chairs: Paul Rogers (Canada), Alexander Karachunsky (Russia)

10.00 – 10.10 Gene expression-based classification and risk stratification of pediatric acute lymphoblastic leukemia (291) – Sun Yanran, Zhang Han, Cheng Hao, Gao Chao, Wang Qingqing, Han Jingdong, Zheng Huyong (China)

10.10 – 10.20 Outcome of Paediatric Philadelphia-Positive Acute Lymphoblastic Leukaemia (Ph+ ALL) Using Aggressive Chemotherapy with Imatinib in India (324) – Brijesh Arora, Kalasekhar Vijayasekharan, Nirav Thackar, Gaurav Narula, Nikhil Patkar, Sumit Gujral, Prashant Tembhare, Mani Subramaniam, Prathibha Amre Kadam, Shripad Banavali (India)

10.20 – 10.30 Impact of cytogenetic evolution on outcome of allogeneic hematopoietic stem cell transplantation at posttransplant relapses in pediatric acute leukemia patients (098) – Tatiana L Gindina, Nikolay Mamaev, Elena Nikolaeva, Olga Slesarchuk, Kirill Ekushov, Olesya Paina, Anastasya Borovkova, Lyudmila Zubarovskaya, Boris Afanasyev (Russia)

10.30 – 10.40 Comparison Between UKALL and Lahore Protocol on Induction Response in Pre B, Acute Lymphoblastic Lymphoma (326) – Safia Khan, Saadia Anwar (Pakistan)

10.40 – 10.50 Characteristics and outcome of MLL gene re- arrangement positive pediatric Acute Lymphoblastic Leukemia: a report on 371 cases (079) – Suleimman Ahmad Al-sweedan, Rafat Jafri, Khawar Siddiqui, Ali Alahmary, Ibrahim Ghemlaz, Naemah Farhan, Amal Al-Seraihi (Saudi Arabia)

10.50 – 11.00 Evaluation of risk factors and patterns of CNS complications in childhood hematological malignancies during early phase of treatment (386) – Zannat Ara, Chowdhury Yakub Jamal, Afiqul Islam, Md Anwarul Karim, ATM Atikur Rahman, Momena Begum, Mehnaz Akter, Lutfor Rahman (Bangladesh)

11.00 – 11.30 Discussion

RED HALL

10.00 – 11.30 Parallel session: Surgery 1

Chairs: Zacharias Zachariou (Cyprus), Igor Kirgizov (Russia)

10.00 – 10.20 Modern surgical strategies in oncology – Devendra Gupta (India)

10.20 – 10.40 Endoscopic surgery in treatment of tumours of thorax – Alexander Razumovsky (Russia)

10.40 – 10.55 Neurosurgical management of medulloblastoma – the Hong Kong experience – Xian Lun Zhu (Hong Kong S.A.R.)

10.55 – 11.05 Modern strategy of pediatric toraco-abdominal surgery – Andrey Ryabov (Russia)

11.05 – 11.15 Surgical options in complex treatment of focal liver lesions in pediatric patients (144) – E. F. Kim, A. V. Filin, A. V. Semenkov, D. S. Burmistrov, O. V. Dimova, T. N. Galjan, E. U. Krjijanovskaia, A. V. Metelin, S. R. Varfolomeeva, D. U. Kachanov, T. V. Shamanskaja, R. A. Moiseenko, A. V. Petrushin (Russia)

11.15 – 11.25 Head and Neck Pediatric Oncologic Surgery in Cuba – Nelido Gonzalez Fernandez (Cuba)

11.25 – 11.30 Discussion

----------------

BLUE HALL

10.00 – 11.30 Satellite symposium: Infection complications at immune compromised patients

Sponsor: Pfizer

Chair: Galina Novichkova (Russia)

10.00 – 10.50 Diagnosing and treatment of invasive aspergillosis – A. Groll (Germany)

10.50 – 11.10 Possibilities of bronco-alveolar lavage in diagnosing of invasive aspergillosis – Alisa Volkova (Russia)

11.10 – 11.30 Complex approach to infection control on clinic – Galina Solopova (Russia)

-----------------

BIG HALL

12.00 – 13.30 Plenary session: Optimization of care for children with haematological diseases and cancer. Improvement of multicentre collaboration.

Chairs: Veronika Skvortsova (Russia), Oleg Chestnov (Switzerland), Alexander Rumyantsev (Russia), Paul Rogers (Canada), Chi-Kong Li (Hong-Kong S.A.R.), Tezer Kutluk (Turkey)

12.00 – 12.15 Modern development of help for the patients with haematological and oncological diseases in the Russian Federation – Veronika Skvortsova (Russia)

12.15 – 12.30 WHO view on pediatric cancer – what’s next? – Oleg Chestnov (Switzerland)

12.30 – 12.45 Transferring of knowledges and organization of multicentre studies: SIOP experience – Paul Rogers (Canada)

12.45 – 13.00 Perspectives of multicentre collaboration in Asia on pediatric hematology/oncology – Chi Kong Li (Hong-Kong S.A.R.)

13.00 – 13.15 UICC experience in educational programms in LMICs – Tezer Kutluk (Turkey)

13.15 – 13.30 Childhood Leukemia and Population Health – What is Connection? – Eva Steliarova-Foucher (France)

--------

BIG HALL

13.30 – 14.30 Lunch satellite symposium: Recent Innovations in the therapy of refractory B-lineage Acute Lymphoblastic Leukemia

Sponsor: Amgen

Chair: Alexander Rumyantsev (Russia), Alexander Karachunsky (Russia)

13.30 – 13.40 Clinical challenges in the treatment of high-risk B-lineage Acute Lymphoblastic Leukemia – Alexander Karachunsky (Russia)

13.40 – 14.00 Immunologic approaches to the treatment of B-lineage Acute Lymphoblastic Leukemia – Guenter Henze (Germany)

14.00 – 14.15 Recruitment of T-lymphocytes: the first BITE antibody blinatumomab. Results of clinical trials in adults – Alexey Maschan (Russia)

14.14 – 15.00 BITE antibody blinatumomab. Results of clinical trials in children - Alexander Karachunsky (Russia)

--------

BIG HALL

14.30 – 16.00 Parallel Session: Histiocytosis/Acute Myeloid Leukemia

Chairs: Milen Minkov (Austria), Michael Maschan (Russia)

14.30 – 14.50 Modern Strategies of Histiocytosis treatment – Milen Minkov (Austria)

14.50 – 15.05 Hemophagocytic Lymphohistiocytosis (HLH): Recent trends in diagnosis and Management – Bharat Agarwal (India)

15.05 – 15.15 Effectiveness, Toxicity and Place of Epigenetic Therapy in Childhood Acute Myeloid Leukemia (239) – Alexander Popa, Valentina Nemirovchenko, George Mentkevich (Russia)

15.15 – 15.25 Study of late effects and permanent consequences of pediatric onset Langerhans cell histiocytosis (343) – Gleb Bronin, Roman Miroshkin, Evgeniy Bezunov, Elizaveta Mironova, Elena Fisun, Yuliya Pashko, Bulat Kurmanov, Elena Promyslova, Lyudmila Sidorenko, Alexander Karelin, Vladimir Kasatkin, Nikolai Volodin (Russia)

15.25 – 15.35 Administrative aspects of the LCH-IV study – Elfriede Thiem (Austria)

15.35 – 15.45 High Level of miR-196b at Newly Diagnosed Pediatric Acute Myeloid Leukemia Predicts a Poor Outcome (262) - Li-hua XU, Qing YAN, Shaoyan Hu (China)

15.45 – 16.00 Discussion

RED HALL

14.30 – 16.00 Parallel session: Solid Tumours 1

Chairs: Torsten Simon (Germany), Denis Kachanov (Russia)

14.30 – 14.40 Treatment of tumours of ovarian in children – Tezer Kutluk (Turkey)

14.40 – 14.50 Treatment of high-risk neuroblastoma: experience of Russian federal centers (251) - Denis Kachanov, Tatyana Shamanskaya, Evgeni Andreev, Sergey Talypov, Rimma Khismatullina, Denis Shevtsov, Elena Skorobogatova, Kirill Kirgizov, Lili Hachatryan, Vitaly Roschin, Yulia Olshanskaya (, Anna Kazakova, Elena Osipova, Elena Raykina, Elena Feoktistova, Alexey Shcherbakov, Galina Tereschenko, Alexey Nechesnyuk, Nikolay Grachev, Michael Maschan, Yury Likar, Svetlana Varfolomeeva (Russia)

14.50 – 15.00 Outcomes of children with Intermediate Risk Neuroblastoma: Experience from a tertiary cancer centre in India (226) – Monica Bhagat, Sajid S Qureshi (India)

15.00 – 15.10 Neuroblastoma with asymptomatic epidural extension: prolonged survival with palliative care (241) – Issarang Nuchprayoon (Thailand)

15.10 – 15.20 Expression of CD133, CD24 in Neuroblastoma and Prognostic Significance (122) – Qiang Zhao (China)

15.20 – 15.30 Outcome of Bones tumors in the childhood – Migdalia Pérez Trejo (Cuba)

15.30 – 15.40 Multimodality Treatment Outcome of Hepatoblastoma: Our experience in a resource limited country (137) – ATM Atikur Rahman, Mehnaz Akter, Momena Begum, Chowdhury Shamsul Hoque Kibria, Afiqul Islam (Bangladesh)

15.40 – 15.50 Behaviorof Soft tissue sarcomas in the childhood in Cuba – Erasmo Gómez Cabrera (Cuba)

15.50 – 16.00 Discussion

------------------------------------

16.30 – 18.30 Plenary session: Acute Myeloid Leukemia/Hematopoietic Stem Cell Transplantation

Chairs: Jeffrey Rubnitz (USA), Boris Afanasiev (Russia), Alexey Maschan (Russia)

16.30 – 16.50 Modern strategies in AML treatment – Jeffrey Rubnitz (USA)

16.50 – 17.10 Present and future challenges in the transplantation of haematopoietic stem cells – Alejandro Madrigal (Great Britain)

17.10 – 17.30 AML treatment: the Asian view – Daisuke Tomizawa (Japan)

17.30 – 17.50 Donor’s choice for HSCT and outcome – Boris Afanasiev (Russia)

17.50 – 18.10 HSCT for AML at children: new strategies – Michael Maschan, Larisa Shelikhova, Alexey Maschan (Russia)

18.10 – 18.20 Action in advance: prevention of postcytostatic neutropenia in hematology – Vadim Ptushkin (Russia)

18.20 – 18.30 Discussion

Friday, May 27

BIG HALL

8.00 – 9.45 Plenary session: Solid Tumours

Chairs: Akira Nakagawara (Japan), Carlos Rodriguez-Galindo (USA)

8.00 – 8.20 Modern neuroblastoma treatment strategies in Asia – Akira Nakagawara (Japan)

8.20 – 8.40 Update on sarcomas diagnosing and treatment – Carlos Rodriguez-Galindo (USA)

8.40 – 9.00 Neuroblastoma treatment options – individualized therapy – Torsten Simon (Germany)

9.00 – 9.20 Neurological signs of neuroblastoma – Kevin Rostasy (Germany)

9.20 – 9.40Actionable targets in neuroblastoma – Konstantin Dobrenkov (USA)

9.40 – 9.45 Discussion

---------------

BIG HALL

10.00 – 11.30 Parallel session: Solid Tumours 2

Chairs: Purna Kurkure (India), Svetlana Varfolomeeva (Russia), Vladimir Polyakov (Russia)

10.00 – 10.10 Spontaneous regression of neurogenic tumours – Barbara Hero (Germany)

10.10 – 10.20 Intraarterial and intravitreal chemotherapy in the combined treatment in children with group C and D intraocular retinoblastoma (201) – Tatiana Ushakova, Olga Gorovtsova, Leonid Martynov, Nune Matinyan, Igor Trofimov, Andrey Yarovoy, Olga Krivovyaz, Svetlana Saakyan, Olga Ivanova, Boris Dolgushin, Vladimir Polyakov (Russia)

10.20 – 10.30 Neoadjuvant transcatheter arterial chemoembolization combined with systemic chemotherapy for treatment of clear cell sarcoma of the kidney (266) – Minju Li, Jinhu Wang, Daxing Tang, Shan Xu, Junqing Mao, Can Lai, Qiang Shu (China)

10.30 – 10.40 Childhood Non Rhabdomyosarcoma Soft Tissue Sarcomas Pattern and Outcome (340) – Mohamed Fawzy Hasan (Egypt)

10.40 – 10.50 Desmoplastic small round cell tumor in children and adolescents: single institution study (382) – Jung Yoon Choi, Hyoung Jin Lee, Che Ry Hong, Kyung Taek Hong, Hyoung Jin Kang, Kyung Duk Park, Hee Young Shin (South Korea)

10.50 – 11.00 Treatment of Wilms' tumour, a single institution experience (355) – Liudmila Shats, Margarita Belogurova (Russia)

11.00 – 11.10 Five Year Experience of Wilms Tumor at a tertiary care centre,where we stand?A developing country perspective (330) – Saadia Anwar, Mahwish Faizan, Safia Khan, Agha Shabbir Ali, Ahsan Waheed Rathore, Alia Ahmad, Mary Taj (Pakistan)

11.10 – 11.20 Monoclonal antibodies and vaccines for pediatric cancer treatment: New immunotherapies approach from Cuban biotechnology – Giselle Saurez Martínez (Cuba)

11.20 – 11.30 Discussion

RED HALL

10.00 – 11.30 Parallel Session: Bone Marrow Donor Registries «Europe-Asia-America»/HSCT

Chairs: Susanne Morsch (Germany), Kirill Kirgizov (Russia)

10.00 – 10.15 European experience in Bone marrow donors search – Susanne Morsch (Germany)

10.15 – 10.30 NMDP experience in donor search and registry organization – Michael Boo (USA)

10.30 – 10.45 Donor registries – the Russian experience – Alexander Alyansky (Russia)

10.45 – 10.55 Survival and treatment of children with acute graft versus host disease: an 8-year single-сentre experience (225) – Andrey Kozlov, Tatyana Bykova, Julia Fedukova, Maxim Kucher, Elena Morozova, Elena Semenova, Anastasya Borovkova, Kirill Ekushov, Sergey Bondarenko, Olga Slesarchuk, Irina Kulagina, Babenko Elena, Alexander Alyansky, Maria Estrina, Lyudmila Zubarovskaya, Boris Afanasyev (Russia)

10.55 – 11.05 Experience of high-dose chemotherapy and autologous hematopoietic stem cell transplantation of pediatric patients with high risk rhabdomyosarcoma (094) – Ju Yeon Lim, Seung Min Hahn, Won Kee Ahn, Jung Woo Han, Moon Kyu Kim, Chuhl Joo Lyu (South Korea)

11.05 – 11.15 Functional activity of platelets and spatial thrombin generation after platelet concentrate transfusion in children after hematopoietic stem cell transplantation (195) - Ekaterina Koltsova, Anna Balandina, Irina Demina, Svetlana Radygina, Fazly Ataullakhanov, Dmitriy Balashov, Mikhail Panteleev (Russia)

11.15 – 11.30 Discussion

-----------

BIG HALL

12.30 – 14.00 Parallelsession: Lymphomas

Chairs: Ilske Osсhlies (Germany), Margarita Belogurova (Russia)

12.30 – 12.45 Burkitt´s lymphoma-new developments – Ilske Osсhlies (Germany)

12.45 – 13.00 Lymphoma in children – Eiichi Ishii (Japan)

13.00 – 13.15 Multicentre Collaboration on childhood lymphoma:report from CCCG Lymphoma Study Group – Yijin Gao (China)

13.15 – 13.25 Treatment of mature B-cell lymphomas with rituximab and reduced intensity chemotherapy – Elena Samochatova, Natalia Myakova (Russia)

13.25 – 13.35 Clinical Profile and prognostic factors in children with sporadic Burkitt’s Lymphoma: An Indian experience (290) – Smitha Hv, Nita Radhakrishnan, Veronique Dinand, Anupam Sachdeva (India)

13.35 – 13.45 Strategy of Treatment Children with Relapse/Refractory Hodgkin’s Lymphoma (302) – Natalia Kulichkina, Elena Belyaeva, George Mentkevich, Alexander Popa (Russia)

13.45 –14.00 Discussion

RED HALL

12.30 – 14.00 Parallel Session: Non-malignant haematology

Chairs: Jing Chen (China), Anna Scherbina (Russia)

12.30 – 12.45 Modern treatment approaches to aplastic anemia at children – Galina Novichkova (Russia)

12.45 – 13.00 Upfront alternate donor HSCT for children with severe aplastic anemia – Jing Chen (China)

13.00 – 13.15 Neutropenic syndromes: modern diagnosing and treatment strategies – Anna Scherbina (Russia)

13.15 – 13.25 Serum interleukin-10 level in childhood immune thrombocytopenia and its role in predicting the clinical course – a prospective case control study (245) – Vinod Gunasekaran, Nita Radhakrishnan, Veronique Dinand, Anupam Sachdeva (India)

13.25 – 13.35 HSCT for patients with non-malignant diseases – Dmitry Balashov (Russia)

13.35 – 13.45 Phenotypic variability in ELANE–related neutropenia from mutated Ala57 residue (358) – Chang-Hun Park, Silvia Park, Yae-Jean Kim, Sun-Hee Kim, Hee-Jin Kim (South Korea)

13.45 – 14.00 Discussion

--------------------

BIG HALL

14.30 – 16.00 Plenary session: CNS Tumours

Chairs: Michael Kam (Hong-Kong S.A.R.), Pablo Hernaiz (Germany)

14.30 – 14.50 Low grade gliomas and modern strategy of diagnostics approach and treatment – Pablo Hernaiz (Germany)

14.50 – 15.10 CNS Germ Cell Tumours – Michael Kam (Hong-Kong S.A.R.)

15.10 – 15.25 Ependymoma: multidisciplinary treatment strategy – Keita Terashima (Japan)

15.25 – 15.35 Nimotuzumab a novel anti-EGFR monoclonal antibody in pediatric brain tumors. Where are the opportunities? – Giselle Saurez Martínez (Cuba)

15.35 – 15.45 Review on the Management & Outcome of Childhood Cerebral or Cerebellar Low Grade Glioma (276) – Godfrey Chi-Fung Chan, Matthew Ming-Kong Shing, Kai-On Chang, Dennis Tak-Noi Ku, Alvin Siu-Cheung Ling, Anthony Pak-Yin Liu (Hong Kong S.A.R.)

15.45 – 15.55 Preliminary results of treatment according to HIT-MED-Study Guideline 2014 in Russian cohort of patients (298) – Ella Kumirova, Sergey Ozerov, Ludmila Papusha, Ekaterina Salnikova, Irina Borodina, Alexey Samarin, Victoria Yemtsova, Anastasia Ektova, Alexey Kislyakov, Marina Ryzhova, Agnessa Panfyorova, Alexey Nechesnyuk, Darya Kobyzeva, Anastasia Usychkina, Anton Artemov, Ludmila Zemtsova, Anna Kazakova, Svetlana Homyakova, Maria Dubrovina, Alexey Pshonkin, Marina Tihonova, Alen Spirin, Sergei Gorelishev, Egor Shorikov, Inna Gerbek, Alexander Shapochnik, Margarita Belogurova, Galina Novichkova, Alexander Karachunskiy, Andge Valiakhmetova, Mikle Andrianov, Galina Tereschenko (Russia)

15.55 – 16.00 Discussion

--------------------------

BIG HALL

16.30 – 18.00 Parallel session: Supporting therapy/Infection control

Chairs: Galina Novichkova (Russia), Zakiya Al lamki (Oman)

16.30 – 16.40 Positive impact of the protocols of empirical anti-infective therapy on the drug resistance index and pharmacoeconomics (308) – Valentina Pirumova, Galina Solopova (Russia)

16.40 – 16.50 Risk Prediction of Fever in Neutropenic Children with Acute Lymphoblastic Leukemia (269) - Lutfor Rahman Molla, Chowdhury Yakub Jamal, Momena Begum, Mehnaz Akter, Md. Bani Yeamin, Md Tanvir Ahammed, S M Rezanur Rahman, Zannat Ara, Rasel Siddique (Bangladesh)

16.50 – 17.00 Invasive fungal diseases in adolescents and young adults after allogeneic hematopoietic stem cell transplantation (227) – Marina Popova, Alisa Volkova, Ayzsilnieks Oksana, Olga Pinegina, Svetlana Ignatyeva, Kirill Ekushev, Olga Slesarchuk, Maria Vladovskaya, Ludmila Stepanovna Zubarovskaya, Nikolay Klimko, Boris Afanasyev (Russia).

17.00 – 17.10 Incidence and clinical spectrum of drug resistant bacterial infections and associated mortality in pediatric hemato-oncology: experience from a tertiary care centre in South India (314) – Atish Narayanrao Bakane, Revathi R Raj, Sreejith R Kurup, Ramya S Uppuluri, Divya S Subburaj (India)

17.10 – 17.20 The results of serologic and bacteriologic examinations of bronchoalveolar lavage for fungal infection in immunocompromised patients (286) – Sviatlana Kandaurava, Olga Aleinikova, Irena Lukyanenka (Belarus)

17.20 – 17.30 Evaluation of Chemotherapy-Induced Oral Mucositis in Pediatric Oncology Hospital (363) – Sarah Mohamed Abdelsamie, Mohamed Abdelrahman, Doaa Abdelmegeed (Egypt)

17.30 – 17.40 Placement of the ommaya reservoir in narrow and slit-like ventricles using a neuronavigation system (127) – Sergey Ozerov, Alexey Samarin, Andrey Melnikov, Ella Kumirova (Russia)

17.40 – 18.00 Discussion

RED HALL

16.30 – 18.00 Parallel Session: Surgery 2

Chairs: Devendra Gupta (India), Alexander Razumovsky (Russia)

16.30 – 16.50 The role of laparascopic surgery in oncologic pediatric patients – Zacharias Zachariou (Cyprus)

16.50 – 17.05 International collaboration in pediatric oncological surgery – Chan Hon Chui (Singapore)

17.05 – 17.15 Microsurgical reconstruction of maxilla and mandible in patients with head and neck tumors - pediatric experience (136) – Nikolay S. Grachev, Sergey V. Tereshuk, Natalia V. Babaskina, Igor N. Vorozhcov, Pavel D. Pryanikov, Margarita P. Kalinina (Russia)

17.15 – 17.25 Current Surgical Strategy for Neuroblastoma – Akihiro Yoneda (Japan)

17.25 – 17.35 Summing up the Results of endoprothesis for children with bone sarcomas: the East-European Sarcoma Group (EESG) (404) – Dmitry Nisichenko, Aslan Dzampaev, Maxim Kubirov, Denis Hestanov, Mamed Aliev (Russia)

17.35 – 17.45 Pediatric oncologic crisis: a challenging brawl! – Shilpa Sharma, Devendra K Gupta (India)

17.45 – 17.55 Treatment outcome of retinoblastoma with combined systemic, intra-arterial, and intravitreal chemotherapy: a single center experience (220) - Won kee Ahn, Seung Min Hahn, Ju Yeon Lim, Jung Woo Han, Dong Joon Kim, Sung Chul Lee, Chuhl Joo Lyu (South Korea)

17.55 – 18.00 Discussion

Saturday, May 28

BIG HALL

8.00 – 10.00 Plenary Session: Late effects. Survivors.

Chairs: Chi-Kong Li (Hong-Kong S.A.R.), Benson Pau (Hong-Kong S.A.R.)

JOINT SESSION: SIOP and CCI

Participants: Physicians, Nurses, CCI-members

8.00 – 8.10 Opening remarks – Chi-Kong Li, Benson Pau

8.10 – 8.30 Late effects in pediatric cancer survivors – Melissa Hudson (USA)

8.30 – 8.40 Psychological aspects in pediatric oncology – Martha Grootenhuis (Netherlands)

8.40 – 8.50 Treatment Abandon: Causes & Solutions – Bharat Agarwal (India)

8.50 – 9.00 Late effects in pediatric oncology – Purna Kurkure (India)

9.10 – 9.20 Quality of life in pediatric cancer patients: 1 month after diagnoses and 12 months later – Shulamit Kreitler (Israel)

9.20 – 9.30 Cancer Survivors: how can we help? – Poonam Bagai (India)

9.30 – 9.40 Modern standards of the psychosocial care for pediatric hematology/oncology patients and their families: challenges of implementation at Dmitry Rogachev Federal Research Center of Pediatric hemnatology, Oncology and Immunology – Alina Khain (Russia)

9.40 – 10.00 Survivors (Olga Basharina, Svetlana Levitskaya)

----------------

BIG HALL

10.30 – 11.30 Special Session: Best Poster oral presentations.

Chairs: Chi-Kong Li (Hong-Kong S.A.R.), Alexander Rumyantsev (Russia), Svetlana Varfolomeeva (Russia)

10.30 – 11.20 9 Best Poster winners oral presentations (5 min. each)

11.20 – 11.30 Discussion

--------------

BIG HALL

12.00 – 13.30 Parallel Session: Modern diagnosing and treatment approach

Chairs: Akira Nakagawara (Japan), Alexander Rumyantsev (Russia)

12.00 – 12.10 Survey on Pediatric Cancer Patients in Kanto-Koshinetsu Area after the Election of Childhood Cancer Core Hospitals in Japan (238) – Kimikazu Matsumoto, Yuki Yuza, Hiroaki Goto, Katsuyoshi Ko, Daisuke Tomizawa, Takashi Kaneko (Japan)

12.10 – 12.20 V(D)J recombination excision circles as markers of T- and B-cell immune reconstitution in patients with acute lymphoblastic leukaemia (123) – Igor V. Obraztsov, Maria A. Gordukova, Ekaterina V. Tsvetkova, Elena V. Kononova, Ivan Y. Tomilin, Andrey P. Prodeus, Alexander G. Rumyantsev (Russia)

12.20 – 12.30 Stromal Collagen type XI Alpha 1 COL11A1 expression in Neuroblastoma (089) – Chi Bao Bui, Hieu Kim Huynh, My Diem Vu, Dinh Khai Truong, Tan Son Vo (Vietnam)

12.30 – 12.40 Relationship between spontaneous and post treatment apoptotic index and apoptotic proteins to prednisolone response and post induction minimal residual disease (MRD) status in pediatric acute lymphoblastic leukemia (ALL) (063) – Bhatia Prateek, Singh Ankita, Trehan Amita, Bansal Deepak, Bhatia Alka, Singh Sachdeva, Man Updesh, Jain Richa (India)

12.40 – 12.50 Rare pediatric renal tumors: always keep in mind. An experience of one laboratory (295) – Anna Mitrofanova, Dmitry Konovalov (Russia)

12.50 – 13.00 Segmental chromosomal alterations have prognostic impact in primary and relapsed neuroblastoma patients (082) – Alexander Druy, Egor Shorikov, Grigory Tsaur, Leonid Saveliev, Larisa Fechina (Russia)

13.00 – 13.10 The efficacy of cyclosporin in the treatment of infant case with subcutaneous panniculitis-like T-cell lymphoma (099) – Michihiro Yano, Miwa Hebigughi, Koya Kodama, Tsutomu Takahashi (Japan)

13.10 – 13.20 Testing of cognitive and emotional behaviour disturbancies in children with ALL (154) – Vladimir Kasatkin, Miroshkin Roman, Karachunskiy Aleksander, Rumyantseva Julia, Zhukovskaya Elena, Malych Sergey, Ismatulina Victoria, Voronin IvanMiroshkin Roman, Karachunskiy Aleksander, Rumyantseva Julia, Zhukovskaya Elena, Малых Сергей/Malyh Sergei, Ismatulina Victoria, Voronin Ivan (Russia)

13.20 – 13.30 Discussion

RED HALL

12.00 – 13.30 Parallel Session: Radiotherapy

Chairs: Hideyuki Sakurai (Japan), Miwako Nozaki (Japan), Rolf-Dieter Kortmann (Germany)

12.00 – 12.15 Modern approaches in radiation oncology in children - Rolf-Dieter Kortmann (Germany)

12.15 – 12.25 Proton beam therapy for pediatric cancer in Japan – Hideyuki Sakurai (Japan)

12.25 – 12.35 The role of radiation therapy for pediatric renal tumor – Miwako Nozaki (Japan)

12.35 – 12.45 First Russian experience in Tomotherapy application for total body irradiation for children (139) – Darya Kobizeva, Alexey Nechesnyuk (Russia)

12.45 – 12.55 An effective stereotactic radiotherapy for recurrent pilomyxoid astrocytoma in the medulla oblongata of pediatric patient (169) – Tamami Yano, Michihiro Yano, Miwa Hebiguchi, Koya Kodama, Tsutomu Takahashi (Japan)

12.55 – 13.05 The role of adjuvant chemotherapy for radiation therapy of diffusely growing tumors of the brain stem in children (148) – Oleg Shcherbenko, Roman Parhomenko, Natalij Zelinskaj, Fedor Antonenko (Russia)

13.05 – 13.15 Interstitial Brachytherapy For Childhood Soft Tissue Sarcomas: Long Term Disease Outcome & Late Effects (292) – Siddhartha Laskar, Nehal Khanna, Ajay Puri, Sajid Qureshi, Ashish Gulia, Tushar Vora, Bharat Rekhi, Seema Media, Girish Chinnaswamy, Shashikant Juvekar, Subhash Desai, Yogesh Ghadi (India)

13.15 – 13.25 Radiation Therapy and Nimotuzumab inChildren and Adolescents with Brainstem Gliomas: A 5-Year Institutional Experience (378) - Migdalia Perez, Jose Alert, Jesus Reno, Mariuska Forteza (Cuba)

13.25 – 13.30 Discussion

BIEGE HALL

12.00 – 13.30 Parallel Session: Psychology and palliative care aspects in pediatric oncology

BIG HALL

14.00 – 15.00 Plenary Session: Modern diagnosing and treatment approach

Chairs: Chi-Kong Li (Hong-Kong S.A.R.), Alexander Rumyantsev (Russia)

Panel discussion:

14.00 – 14.05 Chi-Kong Li

14.05 – 14.10 Alexander Rumayntsev

14.10 – 14.15 Paul Rogers

14.15 – 14.20 Akira Nakagawara

14.20 – 14.40 Open discussion

14.40 – 15.00 Chair's remarks

----------------

BIG HALL

Closing Ceremony

15.30 – 15.35 Farewell words – Chi-Kong Li

15.35 – 15.40 Presentation of SIOP Asia Congress 2017

15.40 – 15.45 Farewell words – Alexander Rumyantsev

15.45 – 16.00 Salutations

Posters

Poster session with Jury – May 26 13.30 – 14.30

Leukemia/Lymphoma

Head: Chi-Kong Li (Hong-Kong S.A.R.)